Warning: The NCBI web site requires JavaScript to function. more...
Development of avian influenza virus H5 DNA vaccine and MDP-1 gene of Mycobacterium bovis as genetic adjuvant.
Jalilian B, Omar AR, Bejo MH, Alitheen NB, Rasoli M, Matsumoto S.
Genet Vaccines Ther. 2010 May 24;8:4.
Related citations
DNA vaccine encoding avian influenza virus H5 and Esat-6 of Mycobacterium tuberculosis improved antibody responses against AIV in chickens.
Oveissi S, Omar AR, Yusoff K, Jahanshiri F, Hassan SS.
Comp Immunol Microbiol Infect Dis. 2010 Dec;33(6):491-503. Epub 2009 Sep 24.
The adjuvant effect of Sophy β-glucan to the antibody response in poultry immunized by the avian influenza A H5N1 and H5N2 vaccines.
Le T, Le T, Doan TH, Quyen D, Le KX, Pham V, Nagataki M, Nomura H, Ikeue Y, Watanabe Y, Agatsuma T.
J Microbiol Biotechnol. 2011 Apr;21(4):405-11.
Fusion of HSP70 gene of Mycobacterium tuberculosis to hemagglutinin (H5) gene of avian influenza virus in DNA vaccine enhances its potency.
Rasoli M, Omar AR, Aini I, Jalilian B, Syed Hassan SH, Mohamed M.
Acta Virol. 2010;54(1):33-9.
Construction and immunogenicity of recombinant fowlpox vaccines coexpressing HA of AIV H5N1 and chicken IL18.
Mingxiao M, Ningyi J, Zhenguo W, Ruilin W, Dongliang F, Min Z, Gefen Y, Chang L, Leili J, Kuoshi J, Yingjiu Z.
Vaccine. 2006 May 15;24(20):4304-11. Epub 2006 Mar 29.
Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.
Veits J, Römer-Oberdörfer A, Helferich D, Durban M, Suezer Y, Sutter G, Mettenleiter TC.
Vaccine. 2008 Mar 20;26(13):1688-96. Epub 2008 Feb 4.
Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector.
Jiang Y, Yu K, Zhang H, Zhang P, Li C, Tian G, Li Y, Wang X, Ge J, Bu Z, Chen H.
Antiviral Res. 2007 Sep;75(3):234-41. Epub 2007 Apr 9.
Improvements to the hemagglutination inhibition test for serological assessment of recombinant fowlpox-H5-avian-influenza vaccination in chickens and its use along with an agar gel immunodiffusion test for differentiating infected from noninfected vaccinated animals.
Swayne DE, Avellaneda G, Mickle TR, Pritchard N, Cruz J, Bublot M.
Avian Dis. 2007 Sep;51(3):697-704.
A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice.
Zheng L, Wang F, Yang Z, Chen J, Chang H, Chen Z.
BMC Infect Dis. 2009 Feb 12;9:17.
Avian influenza in ovo vaccination with replication defective recombinant adenovirus in chickens: vaccine potency, antibody persistence, and maternal antibody transfer.
Mesonero A, Suarez DL, van Santen E, Tang DC, Toro H.
Avian Dis. 2011 Jun;55(2):285-92.
Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin.
Smith LR, Wloch MK, Ye M, Reyes LR, Boutsaboualoy S, Dunne CE, Chaplin JA, Rusalov D, Rolland AP, Fisher CL, Al-Ibrahim MS, Kabongo ML, Steigbigel R, Belshe RB, Kitt ER, Chu AH, Moss RB.
Vaccine. 2010 Mar 16;28(13):2565-72. Epub 2010 Jan 29.
Protection and differentiation of infected from vaccinated animals by an inactivated recombinant Newcastle disease virus/avian influenza H5 vaccine.
Lozano-Dubernard B, Soto-Priante E, Sarfati-Mizrahi D, Castro-Peralta F, Flores-Castro R, Loza-Rubio E, Gay-Gutiérrez M.
Avian Dis. 2010 Mar;54(1 Suppl):242-5.
Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM.
Pediatrics. 2006 Sep;118(3):e579-85.
[Construction and immunogenicity of attenuated Salmonella typhimurium harbouring stable DNA vaccine against H5 subtype of avian influenza virus].
Tang LH, Pan ZM, Cheng NN, Jiao XA, Zhang XM.
Wei Sheng Wu Xue Bao. 2007 Aug;47(4):662-6. Chinese.
The potent adjuvant effects of chicken beta-defensin-1 when genetically fused with infectious bursal disease virus VP2 gene.
Zhang HH, Yang XM, Xie QM, Ma JY, Luo YN, Cao YC, Chen F, Bi YZ.
Vet Immunol Immunopathol. 2010 Jul;136(1-2):92-7. Epub 2010 Mar 4.
[Construction of Helicobacter pylori Lpp20-IL2 DNA vaccine and evaluation of its immunocompetence in C57BL/6 mice].
Yu W, Zhang Y, Jing J, Liu Z.
Wei Sheng Wu Xue Bao. 2010 Apr 4;50(4):554-9. Chinese.
Strategies for improving the efficacy of a H6 subtype avian influenza DNA vaccine in chickens.
Shan S, Jiang Y, Bu Z, Ellis T, Zeng X, Edwards J, Tian G, Li Y, Ge J, Chen H, Fenwick S.
J Virol Methods. 2011 May;173(2):220-6. Epub 2011 Feb 17.
Development and use of fowlpox vectored vaccines for avian influenza.
Bublot M, Pritchard N, Swayne DE, Selleck P, Karaca K, Suarez DL, Audonnet JC, Mickle TR.
Ann N Y Acad Sci. 2006 Oct;1081:193-201. Review.
[Development of IgHV family specific nucleic acid vaccine against lymphoma by construction of fusion gene of immunoglobulin heavy chain variable region and cytokine].
Liu H, Zhu P, Lin NJ, Zhang Y, Bu DF, Wang YJ, Wang YQ, Yang Y.
Zhonghua Yi Xue Za Zhi. 2004 Jan 2;84(1):48-53. Chinese.
Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbits.
Zhu H, Ding X, Chen X, Yao P, Xu F, Xie R, Yang Z, Liang W, Zhang Y, Li Y, Shen J, He P, Guo Z, Su B, Sun S, Zhu Z.
Vaccine. 2011 Jul 26;29(33):5421-3. Epub 2011 Jun 7.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on